Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fed Conditions
NCT00865618
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
Eplerenone 50 mg Tablets Sandoz Inc., USA
DRUG:
Inspra 50 mg Tablets GD Searle LLC, USA
Sponsor
Sandoz